Skip to main content

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in ERAS — Erasca, Inc.

CIK 861177 NEW YORK, NY

Position in ERAS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$4,875,683
+$684,952 QoQ
Shares Held
266,140
+2.8% QoQ
Ownership
0.076%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#80
of 257 holders
Holding Since
Jun 2022
12 quarters on record
Voting authority Sole 44% Shared 0% None 56%

Common Shares in ERAS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. ERAS ranks #62 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ERAS

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,875,683 266,140
2026-03-31 $4,190,731 259,007
2025-03-31 $610,444 445,580
2024-12-31 $1,116,368 444,769
2024-09-30 $993,951 364,085
2023-12-31 $151,957 71,342
2023-09-30 $140,543 71,342
2023-06-30 $196,903 71,342
2023-03-31 $214,738 71,342
2022-12-31 $105,181 24,404
2022-09-30 $148,980 19,100
2022-06-30 $106,387 19,100